McL-1 Is a Relevant Molecular Target for Antisense Oligonucleotide Strategies in Gastric Cancer Cells

Cancer Biology and Therapy - United States
doi 10.4161/cbt.5.10.3224
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

SRC Inhibition Is Still a Relevant Target in Pancreatic Cancer

Oncologist
Cancer ResearchMedicineOncology
2014English

McL-1 Stabilization Confers Resistance to Taxol in Human Gastric Cancer

Oncotarget
Oncology
2017English

Antisense Oligonucleotide Hope for Childhood Epilepsies

Nature Reviews Neurology
Molecular NeuroscienceNeurologyCellular
2020English

Antisense Oligonucleotide Therapy for Neurodegenerative Disease

Journal of Clinical Investigation
Medicine
2006English

Antisense Oligonucleotide Treatment for Human Astrocytoma

Genome Biology
2001English

Claudin-1 Has Tumor Suppressive Activity and Is a Direct Target of RUNX3 in Gastric Epithelial Cells

Gastroenterology
HepatologyGastroenterology
2010English

Nucleolin on the Cell Surface as a New Molecular Target for Gastric Cancer Treatment

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2010English

ICAM-1 as a Molecular Target for Triple Negative Breast Cancer

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2014English

Rac1 Is Correlated With Aggressiveness and a Potential Therapeutic Target for Gastric Cancer

International Journal of Oncology
Cancer ResearchOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy